IMA Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-9
Closed -$1K 328
2018
Q3
$1K Buy
+9
New +$1.36K ﹤0.01% 318
2014
Q3
Sell
-42,825
Closed -$3.53M 168
2014
Q2
$3.53M Sell
42,825
-1,845
-4% -$141K 1.61% 11
2014
Q1
$3.43M Sell
44,670
-2,230
-5% -$174K 1.6% 10
2013
Q4
$3.25M Buy
46,900
+460
+1% +$30.2K 1.54% 11
2013
Q3
$3.01M Buy
46,440
+1,430
+3% +$90.4K 1.48% 14
2013
Q2
$2.62M Buy
+45,010
New +$2.57M 1.42% 13

Other funds holding FBT

IMA Advisory Services's FBT Position: Q4 2018 in Review

IMA Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 9 shares — an estimated $1K sold.

IMA Advisory Services first reported a position in FBT in Q2 2013 and held it in 6 quarters. The position peaked at $3.53M in Q2 2014. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

  • IMA Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
  • IMA Advisory Services sold 9 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $1K.
  • IMA Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 6 quarters.
  • IMA Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.53M in Q2 2014.
  • 194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on IMA Advisory Services's 13F filing for Q4 2018, filed 15 Jan 2019.